NCT03731702

Brief Summary

Background: The human microbiota is the bacteria and other microbes found in and on the human body. Scientists study the microbiota because it is related to many health conditions. The way samples are collected and handled can greatly affect microbiota study findings. Researchers want to learn more about how collection methods affect these studies. Objectives: To compare different oral and fecal collection methods. To test the effect of new methods to get DNA out of these samples. Eligibility: Adults ages 18 and older who are National Cancer Institute employees and have not taken antibiotics in the past 3 months Design: Participants will discuss the study with researchers. Participants will give an oral or fecal sample or both. For the oral sample, participants will be told what not to do beforehand. This includes chewing gum and smoking. Participants will spit saliva into a tube. Then they will get mouthwash in a vial. They will swish and gargle the mouthwash for 30 seconds then spit it back in the vial. Participants giving a fecal sample will get a collection kit. They can collect the sample at home or elsewhere. Participants will have a bowel movement into the collection container. They will smear some of it on a card with a stick and put the rest in 2 tubes. They will mix the feces with the solution in the tubes. Participants will write the date and time of collection on the instructions and return the sample within 24 hours. Participants providing both samples could have 3 study visits: 1 to give an oral sample, 1 to get the fecal sample collection kit, and 1 to return that sample.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Nov 2018

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2018

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

November 3, 2018

Completed
3 days until next milestone

First Posted

Study publicly available on registry

November 6, 2018

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 27, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 27, 2020

Completed
Last Updated

October 28, 2020

Status Verified

October 1, 2020

Enrollment Period

2 years

First QC Date

November 3, 2018

Last Update Submit

October 27, 2020

Conditions

Keywords

Oral MicrobiotaFecal MicrobiotaStability

Outcome Measures

Primary Outcomes (1)

  • Oral and/or fecal microbiota

    relative abundance and phylogenetic diversity of their oral and/or fecal microbiota

    1 month

Study Arms (1)

General Individuals

Any adult working at the NCI who has not used antibiotics in the past 3 months.

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

We plan to recruit 100 adults who work at the NCI, either in Shady Grove or in the Advanced Technology Center (ATC), who are willing to provide oral and/or fecal samples. We will include any participant that is at least 18 years of age or older who is employed at NCI and has not taken antibiotics anytime in the past 3 months since antibiotic use has been shown to disrupt the microbiota.

* ELIGIBILITY CRITERIA: * Adults who work at the NCI, either in Shady Grove or in the Advanced Technology Center (ATC) * Willing to provide oral and/or fecal samples. * At least 18 years of age or older * Not taken antibiotics anytime in the past 3 months

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

Study Sites (1)

NIH NCI Shady Grove

Rockville, Maryland, 20850, United States

Location

Study Officials

  • Emily J Vogtmann, Ph.D.

    National Cancer Institute (NCI)

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
NIH
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 3, 2018

First Posted

November 6, 2018

Study Start

November 1, 2018

Primary Completion

October 27, 2020

Study Completion

October 27, 2020

Last Updated

October 28, 2020

Record last verified: 2020-10

Locations